INM
NASDAQ
$1.59
InMed Pharmaceuticals Inc (INM)
InMed Pharmaceuticals Inc., a clinical-stage pharmaceutical company, researches and develops cannabinoid-based therapies. The company is headquartered in Vancouver, Canada.
Sector:
Healthcare
Target: $20 (+1157.86%)
Market Cap
$5.50M
P/B Ratio
0.81
Revenue 5Y CAGR
+35.36%
Beta (5Y)
1.14
Price Chart
Valuation
Market Cap$5.50M
P/S1.13
P/B0.81
Profitability
Total Revenue (TTM)$3.25M
Gross Profit (TTM)$1.71M
EBITDA-$8.30M
Profit Margin-172.2%
Operating Margin-54.4%
EPS-$3.17
Growth & Risk
EPS 5Y CAGR-65.62%
Revenue 5Y CAGR+35.36%
FCF 5Y CAGR-4.08%
Beta (5Y)1.14
Sharpe Ratio0.26